CECAD’s vision is to use the knowledge gained to develop new therapies for the entire spectrum of aging-associated diseases, including cancer, diabetes, stroke, renal failure, and neurodegenerative disorders.
CECAD creates new synergies through a novel network of innovative minds and ideas. More than 400 international scientists from the University of Cologne, the Cologne University Hospital, the Max Planck Institutes for Metabolism Research and Biology of Ageing, and the German Center for Neurodegenerative Diseases (DZNE) are exploring the molecular basis of the aging process and age-associated diseases at the Cluster of Excellence.